ARTICLE;
DEFIBRILLATION;
DRUG INFORMATION;
DRUG LABELING;
DRUG PACKAGING;
DRUG SAFETY;
ELECTRIC BURN;
ELECTRIC CONDUCTIVITY;
ELECTRIC CURRENT;
ELECTRIC RESISTANCE;
ELECTRIC SHOCK;
ELECTRODE;
HUMAN;
MAGNETIC FIELD;
NUCLEAR MAGNETIC RESONANCE IMAGING;
RISK ASSESSMENT;
TRANSDERMAL PATCH;
ADMINISTRATION, CUTANEOUS;
ALUMINUM;
BURNS;
DRUG DELIVERY SYSTEMS;
HUMANS;
Agence française de sécurité sanitaire des produits de santé Interactions entre dispositifs médicaux implantables actifs et dispositifs médicaux 29 November 2005. Website afssaps.sante.tr accessed 18 May 2006: 5 pages.
Agence française de sécurité sanitaire des produits de santé "Interactions entre dispositifs médicaux implantables actifs et dispositifs médicaux" 29 November 2005. Website afssaps.sante.tr accessed 18 May 2006: 5 pages.
7
0033228531
MR imaging safety considerations
Price R "MR imaging safety considerations" Radiographics 1999; 19: 1641-1651.
Canada Notice to hospitals- Association of transdermal drug patches with thermal burns during magnetic resonance imaging procedures 26 April, Website accessed 15 December 2006: 2 pages
Santé Canada "Notice to hospitals- Association of transdermal drug patches with thermal burns during magnetic resonance imaging procedures" 26 April 2005. Website www.hc-sc.gc.ca accessed 15 December 2006: 2 pages.